首頁 > 市場調查報告書 > 醫療設備

體外診斷人工智能診斷用人工智能

市場調查報告書

商品編碼

1342023

全球診斷市場中的人工智慧：趨勢、機會和競爭分析 [2023-2028]

Artificial Intelligence in the Global Diagnostic Market: Trends, Opportunities and Competitive Analysis [2023-2028]

出版日期: 2023年08月10日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

診斷市場的人工智慧趨勢和預測

人工智慧在全球診斷市場的未來性廣闊，放射學、腫瘤學、神經病學和心臟病學、胸肺病學和病理學市場都有商機。到2028年，全球診斷市場中人工智慧的使用預計將達到 38 億美元，2023年至2028年的年複合成長率為 33.5%。該市場的主要促進因素是降低診斷成本的需求不斷成長，醫療保健領域的技術開拓以及對低成本診斷組件的需求不斷增加。

診斷市場的人工智慧洞察

Lucintel 預測人工智慧驅動的軟體將取得進步，該軟體專為實驗室精確的醫療保健診斷而設計，以及支援人工智慧和以雲端為中心的增強診斷，可在解釋患者醫學影像的同時顯著提高診斷準確性。軟體預計將在預測期間實現最高成長由於對解決方案的需求不斷增加。
由於神經系統疾病罹患率不斷上升，以及世界各地在神經系統疾病病例的治療中採用基於價值的護理的趨勢不斷成長，神經病學和心臟病學將繼續成為最大的細分市場。
由於電子健康記錄(EHR)、遠端醫療服務、其他數位醫療解決方案以及人工智慧主導診斷設備的無縫整合的普及，北美在預測期內可能仍然是最大的地區。

本報告回答了 11 個關鍵問題：

Q1.診斷市場中的人工智慧依組成部分(硬體、軟體、服務)、技術(機器學習、NLP、情境計算、電腦視覺)和診斷類型(放射學、腫瘤學、神經學)和心臟病學、胸肺學、病理學、其他)以及依地區(北美、歐洲、亞太地區、世界其他地區)分類，哪些最有前途且具有最高的成長機會？
Q.2.未來哪個細分市場成長較快？為什麼？
Q.3.哪個地區成長較快，為什麼？
Q.4.影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
Q.5.這個市場的商業風險和競爭威脅是什麼？
Q.6.這個市場有哪些新趨勢？為什麼？
Q.7.市場客戶需求有何改變？
Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
Q.9.這個市場的主要企業有哪些？此外，主要企業採取什麼樣的策略配合措施？
Q10.該市場的競爭產品有哪些？因材料或產品替代而導致市場佔有率下降的威脅有多大？
Q11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

宏觀經濟趨勢(2017-2022)與預測(2023-2028)
全球診斷市場的人工智慧趨勢(2017-2022)和預測(2023-2028)
依組件分類的全球診斷市場中的人工智慧
- 硬體
- 軟體
- 服務
全球診斷市場人工智慧技術分析
- 機器學習
- NLP
- 情境感知運算
- 電腦視覺
按診斷類型分類的全球診斷市場中的人工智慧
- 放射科
- 腫瘤學
- 神經病學和循環系統醫學
- 胸部和肺部
- 病理
- 其他

第4章 2017-2028年分地區市場趨勢及預測分析

依地區分類的全球診斷市場中的人工智慧
北美診斷市場的人工智慧
歐洲診斷市場的人工智慧
亞太診斷市場的人工智慧
其他區域診斷市場的人工智慧

第5章競爭分析

產品系列分析
營運整合
波特五力分析

第6章成長機會與策略分析

成長機會分析
- 全球診斷市場中人工智慧的成長機會(按組成部分)
- 依技術分類的全球診斷市場人工智慧的成長機會
- 按診斷類型分類的全球診斷市場人工智慧的成長機會
- 全球診斷市場人工智慧成長機會(依地區)
全球診斷市場人工智慧新趨勢
戰略分析
- 新產品開發
- 擴大人工智慧在全球診斷市場的能力
- 全球診斷市場的人工智慧合併和收購企業
- 認證和許可

第7章主要企業概況

General Electric
Siemens
Aidoc Medical
AliveCor
Imagen Technologies
VUNO
IDx Technologies
NovaSignal Corporation
Riverain Technologies
Zebra Medical Vision

簡介目錄

Artificial Intelligence in the Diagnostic Market Trends and Forecast

The future of artificial intelligence in the global diagnostic market looks promising with opportunities in the radiology, oncology, neurology & cardiology, chest & lung, and pathology markets. The use of artificial intelligence in the global diagnostic market is expected to reach an estimated $3.8 billion by 2028 with a CAGR of 33.5% from 2023 to 2028. The major drivers for this market are increasing need to lower diagnostic expenses, technological developments in the healthcare sector, and rising demand for low-cost diagnostic components.

A more than 150-page report is developed to help in your business decisions.

Artificial Intelligence in the Diagnostic Market by Segment

The study includes trends and forecast for artificial intelligence in the global diagnostic market by component, technology, diagnosis type, and region as follows:

Artificial Intelligence in the Diagnostic Market by Component [Shipment Analysis by Value from 2017 to 2028]:

Hardware
Software
Services

Artificial Intelligence in the Diagnostic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

Machine Learning
NLP
Context-Aware Computing
Computer Vision

Artificial Intelligence in the Diagnostic Market by Diagnosis Type [Shipment Analysis by Value from 2017 to 2028]:

Radiology
Oncology
Neurology & Cardiology
Chest & Lungs
Pathology
Others

Artificial Intelligence in the Diagnostic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

North America
Europe
Asia Pacific
The Rest of the World

List of Artificial Intelligence Companies in the Diagnostic Market

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, artificial intelligence companies in the diagnostic market cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of artificial intelligence companies in the diagnostic market profiled in this report include:

General Electric
Siemens
Aidoc Medical
AliveCor
Imagen Technologies
VUNO
IDx Technologies
NovaSignal Corporation
Riverain Technologies
Zebra Medical Vision

Artificial Intelligence in the Diagnostic Market Insights

Lucintel forecasts that software is expected to witness the highest growth over the forecast period due to advancement of AI-driven software designed for healthcare diagnosis in test accuracy, as well as increasing requirement for AI-enabled and cloud-centric enhanced diagnostic solutions to improve diagnostic accuracy significantly while interpreting medical imagery of patients.
Neurology & cardiology will remain the largest segment due to rising incidence of neurological disorders and increasing trend of adopting value based care in treating the cases of neurological disorders across the globe.
North America will remain the largest region over the forecast period due to widespread incorporation of electronic health records (EHRs), telehealth offerings, and additional digital healthcare solutions, as well as seamless integration of AI-driven diagnostic instruments.

Features of Artificial Intelligence in the Diagnostic Market

Market Size Estimates: Artificial intelligence in the diagnostic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
Segmentation Analysis: Artificial intelligence in the diagnostic market size by various segments, such as by component, technology, diagnosis type, and region in terms of value ($B).
Regional Analysis: Artificial intelligence in the diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different components, technologies, diagnosis types, and regions for artificial intelligence in the diagnostic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of artificial intelligence in the diagnostic market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is artificial intelligence in the diagnostic market size?
Answer: The use of artificial intelligence in the global diagnostic market is expected to reach an estimated $3.8 billion by 2028.
Q2.What is the growth forecast for artificial intelligence in the diagnostic market?
Answer: The use of artificial intelligence in the global diagnostic market is expected to grow with a CAGR of 33.5% from 2023 to 2028.
Q3.What are the major drivers influencing the growth of artificial intelligence in the diagnostic market?
Answer: The major drivers for this market are increasing need to lower diagnostic expenses, technological developments in the healthcare sector, and rising demand for low-cost diagnostic components.
Q4. What are the major segments for artificial intelligence in the diagnostic market?
Answer: The future of artificial intelligence in the diagnostic market looks promising with opportunities in the radiology, oncology, neurology & cardiology, chest & lung, and pathology markets.
Q5. Who are the key artificial intelligence companies in the diagnostic market?
Answer: Some of the key artificial intelligence companies in the diagnostic market are as follows:
- General Electric
- Siemens
- Aidoc Medical
- AliveCor
- Imagen Technologies
- VUNO
- IDx Technologies
- NovaSignal Corporation
- Riverain Technologies
- Zebra Medical Vision
Q6. Which segment in the diagnostic market in terms of artificial Intelligence usage will be the largest in future?
Answer: Lucintel forecasts that software is expected to witness the highest growth over the forecast period due to advancement of AI-driven software designed for healthcare diagnosis in test accuracy, as well as increasing requirement for AI-enabled and cloud-centric enhanced diagnostic solutions to improve diagnostic accuracy significantly while interpreting medical imagery of patients.
Q7. In the diagnostic market in terms of artificial Intelligence usage, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to widespread incorporation of electronic health records (EHRs), telehealth offerings, and additional digital healthcare solutions, as well as seamless integration of AI-driven diagnostic instruments.
Q.8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

Q1. What are some of the most promising, high-growth opportunities for artificial intelligence in the diagnostic market by component (hardware, software, and services), technology (machine learning, NLP, context-aware computing, computer vision), diagnosis type (radiology, oncology, neurology & cardiology, chest & lungs, pathology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Artificial Intelligence in the Global Diagnostic Market: Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Artificial Intelligence in the Global Diagnostic Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Artificial Intelligence in the Global Diagnostic Market by Component
- 3.3.1: Hardware
- 3.3.2: Software
- 3.3.3: Services
3.4: Artificial Intelligence in the Global Diagnostic Market by Technology
- 3.4.1: Machine Learning
- 3.4.2: NLP
- 3.4.3: Context-Aware Computing
- 3.4.4: Computer Vision
3.5: Artificial Intelligence in the Global Diagnostic Market by Diagnosis Type
- 3.5.1: Radiology
- 3.5.2: Oncology
- 3.5.3: Neurology & Cardiology
- 3.5.4: Chest & Lungs
- 3.5.5: Pathology
- 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

4.1: Artificial Intelligence in the Global Diagnostic Market by Region
4.2: Artificial Intelligence in the North American Diagnostic Market
- 4.2.1: Artificial Intelligence in the North American Diagnostic Market by Component: Hardware, Software, and Services
- 4.2.2: Artificial Intelligence in the North American Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
4.3: Artificial Intelligence in the European Diagnostic Market
- 4.3.1: Artificial Intelligence in the European Diagnostic Market by Component: Hardware, Software, and Services
- 4.3.2: Artificial Intelligence in the European Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
4.4: Artificial Intelligence in the APAC Diagnostic Market
- 4.4.1: Artificial Intelligence in the APAC Diagnostic Market by Component: Hardware, Software, and Services
- 4.4.2: Artificial Intelligence in the APAC Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
4.5: Artificial Intelligence in the ROW Diagnostic Market
- 4.5.1: Artificial Intelligence in the ROW Diagnostic Market by Component: Hardware, Software, and Services
- 4.5.2: Artificial Intelligence in the ROW Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Component
- 6.1.2: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Technology
- 6.1.3: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Diagnosis Type
- 6.1.4: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Region
6.2: Emerging Trends of Artificial Intelligence in the Global Diagnostic Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of Artificial Intelligence in the Global Diagnostic Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures of Artificial Intelligence in the Global Diagnostic Market
- 6.3.4: Certification and Licensing